Richard Roe v. DOD

Court of Appeals for the Fourth Circuit·Decided January 10, 2020·No. 19-1410·Published

Opinion

PUBLISHED

UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

No. 19-1410

RICHARD ROE; VICTOR VOE; OUTSERVE-SLDN, INC., Plaintiffs - Appellees

v.

UNITED STATES DEPARTMENT OF DEFENSE; MARK T. ESPER, in his official capacity as Secretary of Defense; and BARBARA M. BARRETT, in her official capacity as Secretary of the Air Force,

Defendants - Appellants.

HIV MEDICINE ASSOCIATION; AMERICAN ACADEMY OF HIV MEDICINE; GLMA: HEALTH PROFESSIONALS ADVANCING LGBT EQUALITY; INFECTIOUS DISEASES SOCIETY OF AMERICA; SECRETARY ERIC K. FANNING; SECRETARY DEBORAH LEE JAMES; SECRETARY RAY MABUS; DR. LAWRENCE J. KORB; REAR ADMIRAL ALAN M. STEINMAN; CAPTAIN THOMAS T. CARPENTER; AIDS UNITED; THE AMERICAN PUBLIC HEALTH ASSOCIATION; DUKE LAW HEALTH JUSTICE CLINIC; SOUTHERN AIDS COALITION; THE NATIONAL ALLIANCE OF STATE AND TERRITORIAL AIDS DIRECTORS; NMAC,

Amici Supporting Appellees.

Appeal from the United States District Court for the Eastern District of Virginia, at Alexandria. Leonie M. Brinkema, District Judge. (1:18-cv-01565-LMB-IDD)

Argued: September 18, 2019 Decided: January 10, 2020

Before WYNN, DIAZ, and FLOYD, Circuit Judges.

Affirmed by published opinion. Judge Wynn wrote the opinion, in which Judge Diaz and Judge Floyd joined.

ARGUED: Lewis Yelin, UNITED STATES DEPARTMENT OF JUSTICE, Washington, D.C., for Appellants. Geoffrey Paul Eaton, WINSTON & STRAWN LLP, Washington, D.C., for Appellees. ON BRIEF: Joseph H. Hunt, Assistant Attorney General, Ryan D. Newman, Deputy General Counsel, Michael J. Fucci, Associate General Counsel, Mark B. Stern, Marleigh D. Dover, James Y. Xi, Civil Division, UNITED STATES DEPARTMENT OF JUSTICE, Washington, D.C.; G. Zachary Terwilliger, United States Attorney, OFFICE OF THE UNITED STATES ATTORNEY, Alexandria, Virginia, for Appellants. Scott A. Schoettes, LAMBDA LEGAL DEFENSE AND EDUCATION FUND, INC., Chicago, Illinois; Peter Perkowski, OUTSERVE-SLDN, INC., Washington, D.C.; Lauren Gailey, John W.H. Harding, Laura Cooley, WINSTON & STRAWN LLP, Washington, D.C., for Appellees. Peter J. Anthony, Laura Seferian, Washington, D.C., Richard D. Salgado, Dallas, Texas, Monica R. Thompson, DENTONS US LLP, Phoenix, Arizona, for Amici Former Military Officials. Bennett Klein, Chris Erchull, GLBTQ LEGAL ADVOCATES & DEFENDERS, Boston, Massachusetts; Kevin J. Minnick, Adam K. Lloyd, Los Angeles, California, for Amici AIDS United, The American Public Health Association, Duke Law Health Justice Clinic, Southern AIDS Coalition, The National Alliance of State & Territorial AIDS Directors, and NMAC.

WYNN, Circuit Judge:

Richard Roe and Victor Voe are active-duty members of the Air Force. 1 They were discharged when the Air Force determined that their chronic but managed illness—HIV— makes them unfit for military service. Roe and Voe sought a preliminary injunction to maintain the status quo while they challenged their discharges. The district court concluded Roe and Voe were likely to succeed on their claims that their discharges were arbitrary and capricious, in violation of the Administrative Procedure Act, and irrational, in violation of Roe and Voe’s equal protection rights. The Government appeals. For the reasons that follow, we affirm.

I.

A.

In the early 1980s, many young and otherwise healthy people became ill with “a wide array of rare and often deadly infections.” J.A. 656. In the United States alone, thousands died. Researchers identified acquired immunodeficiency syndrome (AIDS) as the reason so many otherwise healthy people died from these infections, but they did not understand the cause of AIDS. The people most frequently diagnosed with AIDS belonged to marginalized and stigmatized groups—gay men, intravenous drug users, Haitians, and hemophiliacs—and the disease acquired the colloquial moniker “gay cancer.” In 1984, researchers discovered that AIDS was caused by the human immunodeficiency virus (HIV), which could infect any person sufficiently exposed. However, “by that time, many

1 Roe and Voe proceed pseudonymously. Documents containing identifying information have been filed under seal. Redacted versions are part of the public record.

Americans already believed the cause of the disease to be a deviant lifestyle, a stigmatizing belief that . . . AIDS [w]as a punishment from God.” J.A. 657. Stigma, fear, and misinformation about HIV persist today.

Unlike some viruses, HIV is not easily transmitted. It cannot be spread by saliva, tears, or sweat, and it is not transmitted through hugging, handshaking, sharing toilets, exercising together, or closed-mouth kissing. HIV may be transmitted when certain infected body fluids—blood, semen, pre-seminal fluid, rectal and vaginal fluids, and breastmilk—encounter damaged tissue, a mucous membrane, or the bloodstream. However, even then, transmission is unlikely. The Centers for Disease Control and Prevention estimate the per-exposure risk of transmitting untreated HIV during the riskiest sexual activity—receptive anal intercourse—to be 1.38%. For other sexual activities, the per-exposure risk of transmitting untreated HIV drops to between 0% and 0.11%. And although the risk of transmitting untreated HIV through blood transfusion is high, people who have been diagnosed with HIV are not permitted to donate blood. Untreated HIV can also be transmitted through other types of exposure, but the risk is low. For needle sharing, the per-exposure risk is 0.63%, and for percutaneous needlestick injuries, the per-exposure risk is 0.23%. For other exposures to untreated HIV—like biting, spitting, and throwing bodily fluids—the CDC found the risk to be “negligible,” meaning transmission of untreated HIV is “technically possible but unlikely and not well documented.” J.A. 599.

In 1996, antiretroviral therapy for HIV became widely available. Today, there is “an effective treatment regimen for virtually every person living with HIV,” and 75% to 80% of people living with HIV are on a one-tablet antiretroviral regimen, which combines the

required medications into a single pill taken daily. J.A. 598. The pills have no special handling or storage requirements and tolerate extreme temperatures well. They have minimal side effects and impose no dietary restrictions. And with adherence to treatment, an HIV-positive person’s viral load becomes “suppressed” within several months and the virus reaches “undetectable” levels shortly thereafter, meaning there are less than 50 virus copies per milliliter of blood. J.A. 597, 795. In addition to medication, individuals with HIV receive viral load testing, which is usually conducted quarterly until the patient reaches an undetectable viral load. Then, testing is reduced to three times a year, and finally, once the viral load is undetectable for two years, testing is reduced to a semiannual basis. Testing is routine and can be performed by a general practitioner. Where on-site testing is unavailable, a blood sample can be shipped to a lab.

Antiretroviral therapy is effective for virtually every person living with HIV.

Usually, the virus develops resistance to antiretroviral therapy only when individuals fail to adhere to their treatment regimens. But even then, switching to a different regimen returns the individual to viral suppression. And failing to adhere to treatment does not result in immediate adverse health consequences. It “often takes weeks for an individual’s viral load to reach a level that would not be considered ‘suppressed.’” J.A. 795. If nonadherence continues, the person enters a clinical latency period during which the person may not have any symptoms or negative health outcomes. This clinical latency period “can last for years,” and “can be reversed by restarting [treatment].” Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Richard Roe v. DOD, (4th Cir. 2020).

Richard Roe v. DOD (Richard Roe v. DOD) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Orloff v. Willoughby
345 U.S. 83 (Supreme Court, 1953)
Burlington Truck Lines, Inc. v. United States
371 U.S. 156 (Supreme Court, 1962)
Abbott Laboratories v. Gardner
387 U.S. 136 (Supreme Court, 1967)
Citizens to Preserve Overton Park, Inc. v. Volpe
401 U.S. 402 (Supreme Court, 1971)
Camp v. Pitts
411 U.S. 138 (Supreme Court, 1973)
Gilligan v. Morgan
413 U.S. 1 (Supreme Court, 1973)
Sampson v. Murray
415 U.S. 61 (Supreme Court, 1974)
Califano v. Sanders
430 U.S. 99 (Supreme Court, 1977)
Califano v. Yamasaki
442 U.S. 682 (Supreme Court, 1979)
Weinberger v. Romero-Barcelo
456 U.S. 305 (Supreme Court, 1982)
United States v. Mendoza
464 U.S. 154 (Supreme Court, 1984)
Goldman v. Weinberger
475 U.S. 503 (Supreme Court, 1986)
Madsen v. Women's Health Center, Inc.
512 U.S. 753 (Supreme Court, 1994)
State Oil Co. v. Khan
522 U.S. 3 (Supreme Court, 1997)
United States v. Hatter
532 U.S. 557 (Supreme Court, 2001)
Nken v. Holder
556 U.S. 418 (Supreme Court, 2009)